Dr. Stephen Glazer and Can-Change member Dr. Michael Vallis have undertaken an international survey that will help them learn more about patient needs during the pandemic and help them shape the medical care of people living with obesity as we move forward through this new era of medicine.
Can-Change member M. Vallis co-authors a paper on the EPOCH study whose results suggest that the COVID-19 pandemic negatively impacted patient care for those living with overweight and obesity and was associated with weight gain and interfered with weight management strategies.
Obesity has a profound impact on quality of life, even in seemingly healthy individuals. Diet, physical activity or exercise and lifestyle changes are the cornerstones of obesity treatment, but medical treatment and bariatric surgery are becoming important. Clinicians and other health care professionals are often ill-equipped to address the important environmental and socioeconomic drivers of the current obesity epidemic.
This research, in which Can-Change member Dr. Michael Vallis participated, explored the psychological, emotional, and social experiences of individuals living with obesity, and perceptions of health care providers. A theoretical thematic analysis was conducted using two theoretical frameworks applied to transcripts from a previous qualitative study.
Obesity is associated with poor outcomes in women with operable breast cancer. Lifestyle interventions (LIs) that help women reduce their weight may improve outcomes. A telephone-based LI led to significant weight loss that was still evident at 24 months, without adverse effects on QOL, hospitalizations, or medical events. Can-Change member Dr. Michael Vallis contributed to this article.